Resources search

“The Global Reference List of 100 Core Health Indicators is a standard set of 100 indicators prioritized by the global community to provide concise information on the health situation and trends, including responses at national and global levels. It contains indicators of relevance to country, regional and global reporting across the spectrum of global health priorities relating to the post-2015 health goals of the Sustainable Development Goals (SDGs). These include the Millennium Development Goals (MDGs) agenda, new and emerging priorities such as noncommunicable diseases, universal health coverage and other issues in the post-2015 development agenda.”

This is document outlines BCH-Africa's strategic vision to help countries in sub-Saharan Africa to meet three of the millennium goals by 2015. These goals are: to help to reduce child mortality; improve maternal health; and combat HIV and AIDS, malaria and other diseases. The strategy sets out four main areas of focus: promoting social ownership of immunisation, to contribute to a rapid reduction in infant and maternal mortality; promoting national partnership and developing community skills to roll back malaria in Africa sustainably; developing individual and community skills to stop the spread of HIV and AIDS and tuberculosis; and using communication approaches that achieve long-lasting social changes to help control HIV, malaria and tuberculosis and resolve other health problems. Accompanying strategic priorities are: integrating health communication interventions; and building human resource capacity in community health promotion with a firm commitment to involving all the main actors and partners to create greater social ownership and sustainability

Drawing from the collective knowledge and analytical work of the many experts who have contributed to this volume, this chapter provides a broader perspective on the relative efficiency and effect on health of a number of interventions than is possible in a single, condition-specific chapter. The objective is to provide information on the cost-effectiveness estimates for 319 interventions covering nearly every disease condition considered in the volume, and the resulting avertable burden of disease. This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health.

Developments since 1996, particularly in the TB/HIV field, have prompted a second edition of this popular manual which provides a pocket-sized guide to the clinical management of TB, particularly in patients suffering from co-infection with HIV. Designed for use by busy clinicians, the manual aims to promote the best possible diagnosis and treatment in low-income countries where the prevalence of TB and HIV infection is high, case loads are heavy, and laboratory support may be limited. With these needs in mind, the manual combines the latest scientific knowledge about TB and HIV with authoritative advice based on extensive field experience in several of the hardest hit countries. Throughout the manual, tables, flow charts, lists of do's and don'ts, questions and answers, and numerous practical tips are used to facilitate quick reference and correct decisions. Information ranges from advice on how to distinguish TB from other HIV-related pulmonary diseases to the simple reminder that in sub-Saharan Africa, anyone with TB is in a high risk group for HIV. Though primarily addressed to clinicians working at district hospitals in sub-Saharan Africa, the manual is also suitable for use in areas of Asia and South America where the problem of TB and HIV co-infection poses a growing clinical challenge

This policy brief aims to define vulnerability in the context of infectious disease and provide a framework for analysis. The framework can be used to identify factors that influence vulnerability to infectious disease, including vulnerability to exposure, infection, progression to disease, progression to severe disease, and the effects of disease. The paper identifies strategic areas for further research, the implications for policy makers and future directions for research, interventions and policy